Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Human genome sciences submits biologics license application to fda for abthrax
Human Genome Sciences, 05/22/09
Human Genome Sciences, Inc. announced that it has submitted a Biologics License Application to the U.S. Food and Drug Administration for its human monoclonal antibody drug ABthrax for the treatment of inhalation anthrax.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09
Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09
Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09
Article Search
Sponsor